• Citer

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

par Muss, Hyman B;Tu, Dongsheng;Ingle, James N;Martino, S;Robert, Nicholas J;Pater, Joseph L;Whelan, Timothy J;Palmer, Michael J;Piccart-Gebhart, Martine ;Shepherd, L;Pritchard, Kathleen;He, Zhi;Goss, Paul E
Référence Journal of clinical oncology, 26, 12, page (1956-1964)
Publication Publié, 2008-04

Article révisé par les pairs

• Détails
• Contenu

Titre:	Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Auteur:	Muss, Hyman B; Tu, Dongsheng; Ingle, James N; Martino, S; Robert, Nicholas J; Pater, Joseph L; Whelan, Timothy J; Palmer, Michael J; Piccart-Gebhart, Martine; Shepherd, L; Pritchard, Kathleen; He, Zhi; Goss, Paul E
Informations sur la publication:	Journal of clinical oncology, 26, 12, page (1956-1964)
Statut de publication:	Publié, 2008-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Age Factors
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- administration & dosage
	Antineoplastic Agents -- adverse effects
	Antineoplastic Agents, Hormonal -- administration & dosage
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- pathology
	Chemotherapy, Adjuvant
	Disease-Free Survival
	Double-Blind Method
	Female
	Humans
	Middle Aged
	Neoplasm Staging
	Neoplasms, Hormone-Dependent -- drug therapy
	Nitriles -- administration & dosage
	Nitriles -- adverse effects
	Placebos
	Quality of Life
	Tamoxifen -- administration & dosage
	Triazoles -- administration & dosage
	Triazoles -- adverse effects
Note générale:	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2007.12.6334
	info:pii/JCO.2007.12.6334
	info:pmid/18332474